When it Comes to Drugs the Washington Post Is So Protectionist It Can't Even Discuss Free Trade

The Washington Post gave us another front page moral hand wringer. A round of treatment of Sovaldi, a new and effective drug for treating Hepatitis C, costs $84,000. With three million people suffering from the disease that comes to $250 billion. Should insurers be required to pay the price? How about government programs like Medicaid?

Yes, that could be a real tough question, but for those not committed to using protectionism to maintain the drug industry's profits, the answer is simple: tr...